[1] |
LIAN W S, NIE H P, YUAN Y F, et al. Clinical Significance of Endothelin-1 And C Reaction Protein in Restenosis After the Intervention of Lower Extremity Arteriosclerosis Obliterans[J]. J Invest Surg, 2021, 34(7):765-770. doi:10.1080/08941939.2019.1690600
doi: 10.1080/08941939.2019.1690600
|
[2] |
SHAO C G, WUREN B T, CHI G Q, et al. Serum inflammatory factors such as MMP-9 are associated with post-percutaneous transluminal angioplastyacute myocardial infarction in coronary heart disease patients complicated by lower extremity arteriosclerosis obliterans[J]. Cell Mol Biol (Noisy-le-grand), 2023, 69(15):38-43. doi:10.14715/cmb/2023.69.15.6
doi: 10.14715/cmb/2023.69.15.6
|
[3] |
ARCHANA S M, MARTIN J S, JOSHUA A B, et al. Association between inflammatory biomarkers and all-cause, cardiovascular and cancer-related mortality[J]. CMAJ, 2017, 189(10): E384-E390. doi:10.1503/cmaj.160313
doi: 10.1503/cmaj.160313
|
[4] |
AMIR A, SEYEDEH B T S, G-M MAJID, et al. Serum C-reactive protein in the prediction of cardiovascular diseases: Overview of the latest clinical studies and public health practice[J]. J Cell Physiol, 2018, 233(11):8508-8525. doi:10.1002/jcp.26791
doi: 10.1002/jcp.26791
|
[5] |
DONG Y, WANG X, ZHANG L F, et al. High-sensitivity C reactive protein and risk of cardiovascular disease in China-CVD study[J]. J Epidemiol Community Health, 2019, 73(2):188-192. doi:10.1136/jech-2018-211433
doi: 10.1136/jech-2018-211433
|
[6] |
IBRAHIM R, TUFAN Ç, YAVUZ K. Endothelin-1 and C Reactive Protein as Potential Biomarkers for Restenosis in Patients with Arteriosclerosis Obliterans[J]. J Invest Surg, 2021, 34(7):771-772. doi:10.1080/08941939.2019.1693668
doi: 10.1080/08941939.2019.1693668
|
[7] |
MEAGHAN E C, BENJAMIN E T, YOGENDRA K. Inflammation, Infection and Venous Thromboembolism[J]. Circ Res, 2021, 128(12):2017-2036. doi:10.1161/circresaha.121.318225
doi: 10.1161/circresaha.121.318225
|
[8] |
SEAN M M, ABHISHEK C. The role of platelet mediated thromboinflammation in acute liver injury[J]. Front Immunol, 2022, 13:1037645. doi:10.3389/fimmu.2022.1037645
doi: 10.3389/fimmu.2022.1037645
|
[9] |
LINA B, ESTHER P, GEMMA A, et al. C-Reactive Protein in Atherothrombosis and Angiogenesis[J]. Front Immunol, 2018, 9:430. doi:10.3389/fimmu.2018.00430
doi: 10.3389/fimmu.2018.00430
|
[10] |
YE M, QIAN X, GUO X J, et al. Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Predict Severity and Prognosis of Lower Limb Arteriosclerosis Obliterans[J]. Ann Vasc Surg, 2020, 64:221-227. doi:10.1016/j.avsg.2019.09.005
doi: 10.1016/j.avsg.2019.09.005
|
[11] |
SLAVEN P, LASZLO K S, MONIKA K O, et al. Neutrophil to lymphocyte ratio predicts intracranial hemorrhage after endovascular thrombectomy in acute ischemic stroke[J]. J Neuroinflammation, 2018, 15(1):319. doi:10.1186/s12974-018-1359-2
doi: 10.1186/s12974-018-1359-2
|
[12] |
SAFA K, CENAI Z, AARON M G, et al. Association Between Neutrophil-Lymphocyte Ratio and 30-Day Infection and Thrombotic Outcomes After Intraventricular Hemorrhage: A CLEAR III Analysis[J]. Neurocrit Care, 2024, 40(2):529-537. doi:10.1007/s12028-023-01774-6
doi: 10.1007/s12028-023-01774-6
|
[13] |
IBA T, LEVY J H. Inflammation and thrombosis: Roles of neutrophils, platelets and endothelial cells and their interactions in thrombus formation during sepsis[J]. J Thromb Haemost, 2018, 16(2):231-241. doi:10.1111/jth.13911
doi: 10.1111/jth.13911
|
[14] |
BRAHM H S, THEJASWINI G, SORA S, et al. Neutrophil interactions with T cells, platelets, endothelial cells, and of course tumor cells[J]. Immunol Rev, 2023, 314(1):13-35. doi:10.1111/imr.13178
doi: 10.1111/imr.13178
|
[15] |
INGRID S, JING W, ELZBIETA K, et al. Imaging the dynamic platelet-neutrophil response in sterile liver injury and repair in mice[J]. Hepatology, 2015, 62(5):1593-1605. doi:10.1002/hep.28003
doi: 10.1002/hep.28003
|
[16] |
JAN R, ANDREAS M, ALEXANDER Z. Role of Platelets in Leukocyte Recruitment and Resolution of Inflammation[J]. Front Immunol, 2018, 9:2712. doi:10.3389/fimmu.2018.02712
doi: 10.3389/fimmu.2018.02712
|
[17] |
ZHANG D C, XU C L, DEEPA M, et al. Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology[J]. Blood, 2016, 127(7):801-809. doi:10.1182/blood-2015-09-618538
doi: 10.1182/blood-2015-09-618538
|
[18] |
CARSTEN D, PETER K, JULIA V, et al. Platelet secretion is crucial to prevent bleeding in the ischemic brain but not in the inflamed skin or lung in mice[J]. Blood, 2017, 129(12):1702-1706. doi:10.1182/blood-2016-12-750711
doi: 10.1182/blood-2016-12-750711
|
[19] |
JIN P, LI X, CHEN J, et al. Platelet-to-neutrophil ratio is a prognostic marker for 90-days outcome in acute ischemic stroke[J]. J Clin Neurosci, 2019, 63:110-115. doi:10.1016/j.jocn.2019.01.028
doi: 10.1016/j.jocn.2019.01.028
|
[20] |
LIN Y, DAI W, CHEN Y, et al. Neutrophil-to-platelet ratio predicts mortality following percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction[J]. Front Physiol, 2022, 13:1011048. doi:10.3389/fphys.2022.1011048
doi: 10.3389/fphys.2022.1011048
|
[21] |
SOMASCHINI A, CORNARA S, DEMARCHI A, et al. Neutrophil to platelet ratio: A novel prognostic biomarker in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention[J]. Eur J Prev Cardiol, 2020, 27(19):2338-2340. doi:10.1177/2047487319894103
doi: 10.1177/2047487319894103
|
[22] |
LIU Y, JIA S D, YAO Y, et al. Impact of high-sensitivity C-reactive protein on coronary artery disease severity and outcomes in patients undergoing percutaneous coronary intervention[J]. J Cardiol, 2020, 75(1):60-65. doi:10.1016/j.jjcc.2019.06.012
doi: 10.1016/j.jjcc.2019.06.012
|
[23] |
MUHAMMED S, CENGIZ B, AYCA G, et al. Prognostic value of C-reactive protein to albumin ratio for long-term outcomes of patients with peripheral arterial disease underwent endovascular treatment[J]. Vascular, 2022, 30(3):481-489. doi:10.1177/17085381211025172
doi: 10.1177/17085381211025172
|
[24] |
WANG A T, LIU J, LI C G, et al. Cumulative Exposure to High-Sensitivity C-Reactive Protein Predicts the Risk of Cardiovascular Disease[J]. J Am Heart Assoc, 2017, 6(10): e005610. doi:10.1161/jaha.117.005610
doi: 10.1161/jaha.117.005610
|